Cre/lox-regulated transgenic zebrafish model with conditional myc-induced T cell acute lymphoblastic leukemia

被引:186
作者
Langenau, DM
Feng, H
Berghmans, S
Kanki, JP
Kutok, JL
Look, AT
机构
[1] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA
[2] Childrens Hosp, Dept Hematol Oncol, Boston, MA 02115 USA
[3] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA
关键词
lymphoma; tal1/scl; lmo2;
D O I
10.1073/pnas.0408708102
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
We have created a stable transgenic rag2-EGFP-mMyc zebrafish line that develops GFP-labeled T cell acute lymphoblastic leukemia (T-ALL), allowing visualization of the onset and spread of this disease. Here, we show that leukemias from this transgenic line are highly penetrant and render animals moribund by 80.7 +/- 17.6 days of life (+/-1 SD, range = 50-158 days). These T cell leukemias are clonally aneuploid, can be transplanted into irradiated recipient fish, and express the zebrafish orthologues of the human T-ALL oncogenes tal1/scl and Imo2, thus providing an animal model for the most prevalent molecular subgroup of human T-ALL. Because T-ALL develops very rapidly in rag2-EGFP-mMyc transgenic fish (in which "mMyc" represents mouse c-Myc), this line can only be maintained by in vitro fertilization. Thus, we have created a conditional transgene in which the EGFP-mMyc oncogene is preceded by a loxed dsRED2 gene and have generated stable rag2-loxP-dsRED2-loxP-EGFP-mMyc transgenic zebrafish lines, which have red fluorescent thymocytes and do not develop leukemia. Transgenic progeny from one of these lines can be induced to develop T-ALL by injecting Cre RNA into one-cell-stage embryos, demonstrating the utility of the Cre/lox system in the zebrafish and providing an essential step in preparing this model for chemical and genetic screens designed to identify modifiers of Myc-induced T-ALL.
引用
收藏
页码:6068 / 6073
页数:6
相关论文
共 42 条
[1]   HOX11L2 expression, defines a clinical subtype of pediatric T-ALL associated with poor prognosis [J].
Ballerini, P ;
Blaise, A ;
Coniat, MBL ;
Su, XY ;
Zucman-Rossi, J ;
Adam, M ;
van den Akker, J ;
Perot, C ;
Pellegrino, B ;
Landman-Parker, J ;
Douay, L ;
Berger, R ;
Bernard, OA .
BLOOD, 2002, 100 (03) :991-997
[2]   tp53 mutant zebrafish develop malignant peripheral nerve sheath tumors [J].
Berghmans, S ;
Murphey, RD ;
Wienholds, E ;
Neuberg, D ;
Kutok, JL ;
Fletcher, CDM ;
Morris, JP ;
Liu, TX ;
Schulte-Merker, S ;
Kanki, JP ;
Plasterk, R ;
Zon, LI ;
Look, AT .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (02) :407-412
[3]   A new recurrent and specific cryptic translocation, t(5;14)(q35;q32), is associated with expression of the Hox11L2 gene in T acute lymphoblastic leukemia [J].
Bernard, OA ;
Busson-LeConiat, M ;
Ballerini, P ;
Mauchauffé, M ;
Della Valle, V ;
Monni, R ;
Khac, FN ;
Mercher, T ;
Penard-Lacronique, V ;
Pasturaud, P ;
Gressin, L ;
Heilig, R ;
Daniel, MT ;
Lessard, M ;
Berger, R .
LEUKEMIA, 2001, 15 (10) :1495-1504
[4]   The UMD-p53 database:: New mutations and analysis tools [J].
Béroud, C ;
Soussi, T .
HUMAN MUTATION, 2003, 21 (03) :176-181
[5]  
DICCIANNI MB, 1994, BLOOD, V84, P3105
[6]  
Driever W, 1996, DEVELOPMENT, V123, P37
[7]   Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis [J].
Eischen, CM ;
Weber, JD ;
Roussel, MF ;
Sherr, CJ ;
Cleveland, JL .
GENES & DEVELOPMENT, 1999, 13 (20) :2658-2669
[8]   Clinical implications of recurring chromosomal and associated molecular abnormalities in acute lymphoblastic leukemia [J].
Ferrando, AA ;
Look, AT .
SEMINARS IN HEMATOLOGY, 2000, 37 (04) :381-395
[9]   Biallelic transcriptional activation of oncogenic transcription factors in T-cell acute lymphoblastic leukemia [J].
Ferrando, AA ;
Herblot, S ;
Palomero, T ;
Hansen, M ;
Hoang, T ;
Fox, EA ;
Look, AT .
BLOOD, 2004, 103 (05) :1909-1911
[10]   Prognostic importance of TLX1 (HOX11) oncogene expression in adults with T-cell acute lymphoblastic leukaemia [J].
Ferrando, AA ;
Neuberg, DS ;
Dodge, RK ;
Paietta, E ;
Larson, RA ;
Wiernik, PH ;
Rowe, JM ;
Caligiuri, MA ;
Bloomfield, CD ;
Look, AT .
LANCET, 2004, 363 (9408) :535-536